Antiretroviral Therapy is Highly Effective Against Incident Hepatitis B Disease Acquisition Among HIV-Infected Adults in Rakai, Uganda

View/ Open
Date
2016Author
Seremba, Emmanuel
Ssempijja, Victor
Kalibbala, Sarah
Gray, Ronald
Wawer, Maria
Nalugoda, Fred
Casper, Corey
Phipps, Warren T.
Ocama, Ponsiano
Thomas, David L.
Reynolds, Steven J.
Metadata
Show full item recordAbstract
Co-infection with HepatitisB(HBV) and HIV iscommonin sub-Saharan Africa (SSA) and accelerates progression of liver disease to cirrhosis, hepatocellular carcinoma (HCC) andother complications. About 60% of HCC in Africa is attributed to HBV. In Uganda, 80% of HCC patients have HBVand20%have HIV/HBV coinfection.HCCis the 4th commonest cancer among Ugandan males and
the 6th commonest in females. It is almost always a fatal malignancy in SSA. Prevention of HBV is best achieved through vaccination. Vaccination of HIV-infected adults for HBV is standard of care in developed countries but not in SSA where HBV is believed to be acquired in childhood and where there is lack of HBV incidence data. We investigated the incidence and risk factors associated with HBV among HIV-infected adults in Rakai, Uganda.
Collections
- Medical and Health Sciences [3684]